Cyclacel Pharmaceuticals (CYCC) 10-Q2020 Q1 Quarterly report

Filed: 12 May 20, 5:16pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: agency, Arcadia, breach, broader, Brookline, brought, cent, chain, characterized, charitable, charity, China, choose, comply, confidence, consummation, correction, Delaware, Department, difficult, disease, disrupt, disrupted, diversion, division, economy, Edinburgh, emerge, emerged, emergency, epidemic, evidence, evidenced, fadraciclib, fight, Fisher, fractional, health, hedging, hold, home, Hubei, increasingly, infected, inflammatory, injury, interbank, interrupt, Ladenburg, LIBOR, lieu, LifeArc, London, lung, medical, medicine, mentioned, movement, MTA, multiplying, national, nearest, Organization, outbreak, pace, pandemic, party, pause, placement, preceding, President, Proportionate, protect, Province, recession, reform, request, retroactively, Roth, rounded, Secretary, shelter, significantly, situation, slightly, State, stay, STOPCOVID, strain, stringent, suitability, surfaced, Thalmann, thereunder, Thermo, Transfer, transport, travel, treat, twenty, ultimate, unanimously, uncertain, unchanged, world, Wuhan

Removed: approach, comparable, consultancy, contractual, criterion, FASB, fulfillment, leasing, model, outcome, prescribed, recast, retrospective, SA, satisfaction, ThermoFisher, transition, unsatisfied, vesting

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated CYCC transcripts

CYCC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

Certification of Principal Financial Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. s 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Cyclacel Pharmaceuticals, Inc. ( the “Company”) hereby certifies, to such officer’s knowledge, that:

(i)

the Quarterly Report on Form10-Q of the Company for the three months ended March 31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 12, 2020	/s/ Paul McBarron
	Paul McBarron
	Chief Operating Officer, Chief Financial Officer
	and Executive Vice President, Finance

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.